← Back to all recalls
DRUG RECALLMODERATE
Semaglutide Injection 2 mg Multi-Dose Vials
New Life Pharma recalls semaglutide 2 mg vials over sterility concerns.
What to do
Stop using the recalled semaglutide vials and contact New Life Pharma LLC for instructions on return and replacement.
Why it was recalled
New Life Pharma LLC is recalling semaglutide injection 2 mg multi-dose vials due to a lack of assurance of sterility. The affected product is a sterile prescription medication used for glycemic control and weight management.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Strength | NDC / UPC | Recall # |
|---|---|---|---|
| Semaglutide Inj | 2 mg | NDC 84223-001-06 | D-0393-2026 |
| Semaglutide Inj | 2 mg | NDC 84223-001-07 | D-0392-2026 |
| Tirzepatide Inj | 10 mg | NDC 84223-002-03 | D-0394-2026 |
| Tirzepatide Inj | 15 mg | NDC 84223-002-04 | D-0395-2026 |
Where it was sold
Distributed in Ohio.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
← Back to all recalls
Editorial summary by Recall Canary · summary updated 2026-08-20 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification